The U.S. Food and Drug Administration said an advisory panel will discuss the development of Ebola vaccines, days after an American health worker was flown back after being tested positive for Ebola in Sierra Leone.
The federal health regulator would discuss the development of vaccines on May 12, it announced on its website on Wednesday.